Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
β-D-mannuronic acid in patients with multiple sclerosis
IRCT2016111313739N6Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of D-mannuronic acid in multiple sclerosis (MS), sponsored by Tehran University of Medical Sciences. Started Apr 2017; status: completed.
02
Drugs
D-mannuronic acid
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT2016111313739N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016111313739N6.